Level Four Advisory Services’s RenovoRx RNXT Stock Holding History

Level Four Advisory Services’s Portfolio RNXT Stock Details RNXT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-15,000	Closed	-$19.9K	–	844
2023 Q3	$19.9K	Hold	15,000	–	–	﹤0.01%	734
2023 Q2	$33.9K	Buy	15,000 +5,000	+50%	+$12.1K	﹤0.01%	788
2023 Q1	$34.9K	Buy	+10,000	New	+$35.2K	﹤0.01%	746

Other funds holding RNXT

NPT

Nixon Peabody Trust Boston, Massachusetts $1.26B AUM 24.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

ACA

Affinity Capital Advisors Berkeley, California $810M AUM 24.85% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Level Four Advisory Services's RNXT Position: Q4 2023 in Review

Level Four Advisory Services sold out of RenovoRx (RNXT) in Q4 2023, closing a stake of 15,000 shares — an estimated $19.9K sold.

Level Four Advisory Services first reported a position in RNXT in Q1 2023 and held it in 3 quarters. The position peaked at $34.9K in Q1 2023. 12 funds tracked by Wall St. Rank hold RNXT as of Q4 2023.

Level Four Advisory Services reported no remaining RenovoRx position as of Q4 2023 after selling out during the quarter.
Level Four Advisory Services sold 15,000 RenovoRx shares in Q4 2023, an estimated $19.9K.
Level Four Advisory Services first reported a position in RenovoRx in Q1 2023 and held it in 3 quarters.
Level Four Advisory Services's RenovoRx position peaked at $34.9K in Q1 2023.
12 funds tracked by Wall St. Rank held RenovoRx as of Q4 2023.

Based on Level Four Advisory Services's 13F filing for Q4 2023, filed 8 Feb 2024.